Compare BIO & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | FLR |
|---|---|---|
| Founded | 1952 | 1912 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Military/Government/Technical |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.7B |
| IPO Year | N/A | 2006 |
| Metric | BIO | FLR |
|---|---|---|
| Price | $266.30 | $47.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $358.50 | $53.50 |
| AVG Volume (30 Days) | 238.3K | ★ 2.4M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,503,000,000.00 |
| Revenue This Year | $2.74 | $6.15 |
| Revenue Next Year | $3.05 | $7.31 |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $211.43 | $29.20 |
| 52 Week High | $343.12 | $57.50 |
| Indicator | BIO | FLR |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 51.43 |
| Support Level | $262.83 | $43.11 |
| Resistance Level | $289.61 | $52.05 |
| Average True Range (ATR) | 7.38 | 1.86 |
| MACD | 0.59 | -0.03 |
| Stochastic Oscillator | 24.43 | 67.10 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $15.5 billion in revenue in 2025.